本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Pasithea Therapeutics Corp.

0.5300
-0.0100-1.85%
盤後0.53000.00000.00%17:25 EDT
成交量:14.11萬
成交額:7.50萬
市值:1,770.97萬
市盈率:-0.36
高:0.5515
開:0.5310
低:0.5202
收:0.5400
52周最高:2.06
52周最低:0.2810
股本:3,341.44萬
流通股本:1,020.20萬
量比:0.66
換手率:1.38%
股息:- -
股息率:- -
每股收益(TTM):-1.4820
每股收益(LYR):-2.9100
淨資產收益率:-65.49%
總資產收益率:-36.00%
市淨率:0.36
市盈率(LYR):-0.18

資料載入中...

2022/06/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/27

重要事件披露

8-K/A [Amend] - Current report
2022/06/24

重要事件披露

8-K - Current report
2022/06/24

重要事件披露

8-K/A [Amend] - Current report
2022/06/22

重要事件披露

8-K - Current report
2022/06/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/10

重要事件披露

8-K - Current report
2022/06/01

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/05/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/12

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/21

重要事件披露

8-K - Current report
2021/12/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/14

SEC問詢函

CORRESP [Cover] - Correspondence
2021/12/09

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/11/29

重要事件披露

8-K - Current report
2021/11/18

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]